Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1969 1
1970 1
1971 5
1972 5
1973 4
1974 4
1975 5
1976 5
1977 6
1978 3
1979 6
1980 6
1981 3
1982 12
1983 16
1984 5
1985 12
1986 8
1987 11
1988 9
1989 16
1990 17
1991 13
1992 19
1993 17
1994 10
1995 22
1996 19
1997 15
1998 14
1999 19
2000 26
2001 20
2002 17
2003 20
2004 22
2005 21
2006 20
2007 14
2008 23
2009 14
2010 10
2011 5
2012 17
2013 13
2014 7
2015 9
2016 8
2017 8
2018 7
2019 7
2020 11
2021 4
2022 16
2023 13
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

621 results

Results by year

Filters applied: . Clear all
Page 1
Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial.
Flaadt T, Ladenstein RL, Ebinger M, Lode HN, Arnardóttir HB, Poetschger U, Schwinger W, Meisel R, Schuster FR, Döring M, Ambros PF, Queudeville M, Fuchs J, Warmann SW, Schäfer J, Seitz C, Schlegel P, Brecht IB, Holzer U, Feuchtinger T, Simon T, Schulte JH, Eggert A, Teltschik HM, Illhardt T, Handgretinger R, Lang P. Flaadt T, et al. Among authors: lode hn. J Clin Oncol. 2023 Jun 10;41(17):3135-3148. doi: 10.1200/JCO.22.01630. Epub 2023 Feb 28. J Clin Oncol. 2023. PMID: 36854071 Free PMC article. Clinical Trial.
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial.
Ladenstein R, Pötschger U, Valteau-Couanet D, Luksch R, Castel V, Yaniv I, Laureys G, Brock P, Michon JM, Owens C, Trahair T, Chan GCF, Ruud E, Schroeder H, Beck Popovic M, Schreier G, Loibner H, Ambros P, Holmes K, Castellani MR, Gaze MN, Garaventa A, Pearson ADJ, Lode HN. Ladenstein R, et al. Among authors: lode hn. Lancet Oncol. 2018 Dec;19(12):1617-1629. doi: 10.1016/S1470-2045(18)30578-3. Epub 2018 Nov 12. Lancet Oncol. 2018. PMID: 30442501 Clinical Trial.
Pharmacodynamics of fluoroquinolones.
Lode H, Borner K, Koeppe P. Lode H, et al. Clin Infect Dis. 1998 Jul;27(1):33-9. doi: 10.1086/514623. Clin Infect Dis. 1998. PMID: 9675446 Review.
Impact of Bacterial Toxins in the Lungs.
Lucas R, Hadizamani Y, Gonzales J, Gorshkov B, Bodmer T, Berthiaume Y, Moehrlen U, Lode H, Huwer H, Hudel M, Mraheil MA, Toque HAF, Chakraborty T, Hamacher J. Lucas R, et al. Among authors: lode h. Toxins (Basel). 2020 Apr 2;12(4):223. doi: 10.3390/toxins12040223. Toxins (Basel). 2020. PMID: 32252376 Free PMC article. Review.
Pneumococcal vaccination.
de Roux A, Lode H. de Roux A, et al. Among authors: lode h. Eur Respir J. 2005 Dec;26(6):982-3. doi: 10.1183/09031936.05.00119705. Eur Respir J. 2005. PMID: 16319323 Free article. No abstract available.
Toxicity of quinolones.
Stahlmann R, Lode H. Stahlmann R, et al. Among authors: lode h. Drugs. 1999;58 Suppl 2:37-42. doi: 10.2165/00003495-199958002-00007. Drugs. 1999. PMID: 10553703 Review.
[Therapy of tuberculosis].
Schaberg T, Lode H. Schaberg T, et al. Among authors: lode h. Dtsch Med Wochenschr. 1990 Nov 23;115(47):1799-802. doi: 10.1055/s-2008-1065229. Dtsch Med Wochenschr. 1990. PMID: 2226195 Review. German. No abstract available.
[Therapy of sarcoidosis].
Schaberg T, Schönfeld N, Loddenkemper R, Lode H. Schaberg T, et al. Among authors: lode h. Dtsch Med Wochenschr. 1995 May 19;120(20):725-7. doi: 10.1055/s-2007-1024056. Dtsch Med Wochenschr. 1995. PMID: 7758412 Review. German. No abstract available.
The pharmacokinetics of sultamicillin.
Lode H, Hampel B, Bruckner G, Koeppe P. Lode H, et al. APMIS Suppl. 1989;5:17-22. APMIS Suppl. 1989. PMID: 2660866 Review.
[Community-acquired pneumonia].
Kemmerich B, Rahlwes M, Vogel-Hartmann H, Bartmann K, Höffken G, Berntsson E, Ruckdeschel G, Wagner J, Lode H. Kemmerich B, et al. Among authors: lode h. Dtsch Med Wochenschr. 1989 Sep 29;114(39):1471-7. doi: 10.1055/s-2008-1066784. Dtsch Med Wochenschr. 1989. PMID: 2791899 German.
621 results